One sentence summary: Pleiotropic factor SCO5351 impacts both secondary metabolism and morphological development in Streptomyces coelicolor.
INTRODUCTION
Streptomyces species produce a great variety of secondary metabolites, some of which are bioactive compounds such as antibiotics and other medicines (Hopwood 2007) . In Streptomyces, the genes dedicated for production of a specific antibiotic, including genes for the building of the chemical backbone, for export of the compound, and for conferring resistance, usually form a gene cluster, and in most clusters there are also one or more cluster-situated regulators (CSRs), usually pathway-specific regulators that control expression of structural genes within that cluster (Narva and Feitelson 1990; Fernandez-Moreno et al. 1991; van Wezel and McDowall 2011; Galagan et al. 2013) . In addition to the CSRs, regulatory factors beyond a specific gene cluster often influence expression of the cluster, thereby modulating levels of the antibiotic (van Wezel and McDowall 2011; Galagan et al. 2013 ).
The Streptomyces model strain S. coelicolor produces a few well-studied antibiotics, including its signature blue pigment actinorhodin (ACT), undecylprodigiosin (RED), and the calciumdependent lipopeptide antibiotic (CDA) (Hopwood 2007) . The gene clusters responsible for biosynthesis of these compounds have been characterized, with at least one CSR in each cluster: actII-ORF4 for the ACT pathway (Fernandez-Moreno et al. 1991) ; redD and redZ for the RED pathway (Malpartida et al. 1990; Narva and Feitelson 1990) ; and cdaR for the CDA pathway (Ryding, Anderson and Champness 2002) . Although actII-ORF4 is critical for the production of ACT, as redD and redZ are for RED, and cdaR is for CDA, numerous regulatory factors located elsewhere in the genome, usually ones with broad regulatory roles, also contribute to regulating the production of ACT and other antibiotics. Examples of such broad regulators include the two-component systems (TCSs) AfsQ1/Q2 (Ishizuka et al. 1992; Wang et al. 2013; Chen et al. 2016) , PhoPR (Sola-Landa, Moura and Martin 2003) and DraRK (Yu et al. 2012; Yu et al. 2014) . ACT production can also be influenced by MtrA, a newly identified and critical developmental regulatory factor (Zhang et al. 2017) , and by many other genetic factors (van Wezel and McDowall 2011; Liu et al. 2013) , implying a complex regulatory network for the production of these important compounds.
The genome sequence of S. coelicolor revealed over nine hundred genes with predicted regulatory functions (Bentley et al. 2002) , but the role of most regulatory genes remains unclear. Genome-wide transposition mutagenesis analysis suggested a potential role for SCO5351, an uncharacterized regulator, in antibiotic production (Xu et al. 2017) . In this study, the role of SCO5351 was investigated, and our findings suggest that SCO5351 is a pleiotropic regulator involved in the control of secondary metabolism and development in S. coelicolor.
MATERIALS AND METHODS
The bacterial strains and plasmids used in this study are listed in Supplementary Table S1, and the primers are listed in Supplementary Table S2 . Supplementary Methods contains detailed procedures for the deletion of sco5351, complementation of the sco5351 mutant, mutation of the putative dimerization residues of SCO5351, purification of the wild-type and mutated forms of His-tagged SCO5351, measurement of antibiotics, and preparation of samples for scanning electron microscopy (SEM).
Growth conditions
S. coelicolor M145 and derivative stains were incubated at 30
• C on MS medium for conjugation and preparation of spores or on YBP agar for RNA extraction and phenotype observation (Ou et al. 2009) . Escherichia coli ET12567 (pUZ8002) was used as the donor in conjugation, and E. coli strains DH5a and Transsetta were used for general cloning and protein expression, respectively. All E. coli strains were cultured either in Luria-Bertani (LB) broth or on agar, with antibiotics added as necessary.
RNA extraction and real-time PCR assay
Spores (2 × 10 6 ) of M145 and mutant strains were plated on YBP agar medium already covered with cellophane, followed by incubation at 30
• C, and mycelium was harvested and processed essentially as described (Zhang et al. 2014) . Chromosomal DNA was removed from RNA samples by DNaseI treatment. Real-time PCR was performed with SYBR Premix Ex Taq using the manufacturer's recommended thermal cycler conditions for amplifying cDNA and for determining the melting curve and specificity of PCR products; hrdB, which encodes the major sigma factor in S coelicolor, was used as the control.
RESULTS

Bioinformatics analysis of SCO5351, a putative regulatory protein in S. coelicolor
In the Streptomyces model strain S. coelicolor, sco5351 was annotated as encoding a putative regulatory protein of unknown function. Proteins with high sequence identity to SCO5351 are widely distributed in Streptomyces. For example, SCO5351 has 98% amino acid identity to SLI 5620 from S. lividans, 86% identity to SAV 2921 from S. avermitilis, 80% identity to SCLAV 4247 from S. clavuligerus, and 79% identity to SVEN 5003 from S. venezuelae (Fig. S1 ), suggesting that SCO5351 and its homologues have a conserved role in Streptomyces. Interestingly, sco5351 and its upstream (arg-tRNA) and downstream (sco5352, encoding a putative arg-tRNA snythetase) genes form a syntenic region conserved in the 10 Streptomyces genomes available on StreDB (http://strepdb.streptomyces.org.uk) (Fig. S2) , and most likely among other streptomycetes. Bioinformatics analysis indicated that SCO5351 contains a putative signal receiver domain at the N-terminus and exhibits a low to moderate similarity to known response regulators such as CseB (Paget, Leibovitz and Buttner 1999) , MtrA (Zhang et al. 2017) , RapA1 (Lu et al. 2007 ), AfsQ1 (Wang et al. 2013) 
Deletion of sco5351 from S. coelicolor M145
According to the genome annotation, sco5351 and the upstream arg-tRNA are divergently transcribed and separated by an 180-bp intergenic region, but sco5351 is transcribed in the same direction with its downstream gene sco5352, separated by a 122-bp intergenic sequence (Fig. 1A) . The long intergenic sequence suggests that these two genes are unlikely to form an operon. To investigate the role of SCO5351, a 363-bp region was deleted from S. coelicolor strain M145, leaving the first 96 bp (relative to the start codon) and the last 45 bp (relative to the stop codon) of the 504-bp coding sequence of sco5351, generating sco5351 (Fig. 1A) . This deletion was not expected to affect expression of sco5352. The deletion in the sco5351 coding sequence was verified by PCR using primers next to the deleted region, which generated a 624-bp amplicon for the parental strain M145 and a 1100-bp amplicon for sco5351 (Fig. 1B) , as expected, and confirmed by sequencing of the PCR product ( Fig. 1D-E) .
Mutation of SCO5351 affects production of ACT and CDA
To discover phenotypic changes associated with the deletion of sco5351, cultures of sco5351 and M145 were compared on different media, including MS, R2, R2YE and YBP, with the most striking difference observed on YBP medium ( Fig. 2A) . Production of ACT was largely blocked in sco5351 compared with the abundant production in M145, as evidenced by the heavy blue pigment surrounding the growth patch of the parental strain but not of the mutant ( Fig. 2A) . However, the strikingly reduced production of ACT was not due to poor growth of sco5351, as both M145 and sco5351 demonstrated similar growth curves under the conditions tested (Fig. 2B ), suggesting that SCO5351 does not affect cell growth. To verify the effect of sco5351 deletion on ACT production, intracellular and extracellular ACT levels were measured by spectrophotometer using mycelium of these strains ( Fig. 2C-D) . When compared with M145, production of intracellular and extracellular ACT by sco5351 was significantly lower, remaining close to basal levels, especially in the late growth phase ( Fig. 2C-D) , which was consistent with the observation of nearly complete blockage of ACT production on solid plates ( Fig. 2A) . In addition, a bioassay indicated that production of CDA was notably reduced at 36 h in sco5351 compared with M145, although production increased in the mutant at later time points (Fig. 2E) . Collectively, our analyses indicated that SCO5351 acts as an activator for ACT and CDA biosynthesis and that its deletion leads to reduced production of ACT and CDA in sco5351 under the conditions tested.
To confirm that the altered production of ACT and CDA was a direct effect of the sco5351 mutation, sco5351 was complemented by pCom-5351, a pMS82-based plasmid that contains the upstream (216 bp) and downstream (98 bp) intergenic sequence and the entire coding sequence of sco5351, to generate C-sco5351. Complementation with sco5351 restored production of ACT ( Fig. 2A-D) and CDA ( Fig. 2E ) to levels similar to those of M145, supporting our identification of SCO5351 as a novel regulator of ACT and CDA production.
SCO5351 activates the ACT gene cluster including actII-ORF4
To investigate the mechanism underlying the markedly reduced production of ACT by sco5351, the transcription of ACT cluster genes was compared in strain M145 and sco5351 using RNA extracted at 12-h intervals from 24 to 84 h after plating, the main time period for the production of ACT (Fig. 3) . Genes of the ACT cluster appear to form several operons (Fig. 3A) : actVI-1 to actVA-6 (sco5072-81), actII-2 to actII-3 (sco5083-84), and actI-1 to actVB (sco5087-92). The pathway-specific actII-orf4 (sco5085) is predicted to be transcribed independently, given its distance (149 bp) from the upstream gene actII-orf3 (sco5084) and opposite orientation to the gene immediately downstream, actIII (sco5086). Deletion of SCO5351 affects production of ACT and CDA. (A) ACT production. M145, sco5351, the complemented strain C-sco5351, and sco5351 containing the vector pMS82 (V-sco5351) were cultured on YBP solid medium. Images were taken at the indicated times. The blue pigment in the colonies is ACT. (B) Growth curves of strains M145, sco5351 and C-sco5351. The three strains were cultured on YBP medium, and the dry weight of each strain was measured at the indicated times. (C-D) Extracellular and intracellular levels of ACT. M145, sco5351 and C-sco5351 were cultured on YBP medium, and ACT was measured (C) in agar and (D) harvested cells. Data are the means with standard deviation from three sets of experiments. (E) Analysis of CDA production by bioassay. M145, sco5351 and C-sco5351 were grown on YBP for 36 h, 48 h and 72 h, and were transferred as plugs onto plates containing the indicator strain. CDA production was evaluated by the size of the inhibition zone for the indicator strain, Staphylococcus aureus.
To evaluate transcription of the ACT cluster in the presence and absence of SCO5351, we selected representative genes from most of the operons in the region and genes predicted to be transcribed alone. Expression of each gene at 24 h in strain M145 was arbitrarily set to one (Fig. 3B) : actVI-A (sco5071), which codes a putative hydroxylacyl-CoA dehydrogenase and which is divergently transcribed from actVI-1 (sco5072), exhibited no obvious difference in expression between M145 and sco5351 at 24 h and 36 h; however, by 48 h, its expression had sharply increased to peak values in both strains, reaching levels greater than the control by 113 ± 58-fold in M145, but only by 29 ± 11-fold in sco5351, a value nearly four-fold lower than in M145. Expression of actVI-A (sco5071) was reduced thereafter in both strains but remained markedly higher in M145 (Fig. 3B) . A similar temporal transcription pattern was detected for the following genes: actVI-1, the first gene of the actVI-1 to actVA-6 (sco5072-81) operon and which encodes a putative hydroxylacyl-CoA dehydrogenase; actIII (sco5086), encoding a putative ketoacyl reductase;
and actI-1 (sco5087), encoding the ACT polyketide beta-ketoacyl synthase alpha subunit. These genes showed differential expression between M145 and sco5351 at 48 h, at which time there was also a marked increase in expression compared with levels at 36 h. Peak expression was achieved by 48-60 h and remained significantly higher in M145 than in sco5351 at later time points.
In contrast to the structural genes tested above, actII-orf2 (sco5083), which encodes the putative ACT transporter, showed only minor changes in expression at 48 h (3.9 ± 1.0-fold increase in M145 vs. 1.6 ± 0.3-fold increase in sco5351); more marked changes occurred by 60 h (12.4 ± 4.4-fold and 4.0 ± 1.1-fold increases in M145 and sco5351, respectively), with the notable differences in expression between the two strains maintained at 72 h and 84 h. The delayed peak expression of actII-orf2 (sco5083) compared with the other structural genes is consistent with its role as a transporter, in that it would only be required for export after the synthesis of ACT. The temporal expression of the critical regulatory gene actIIorf4 (sco5085) was similar in both strains at 24 h and 36 h but diverged markedly by 48 h, with the increase in M145 (24.2 ± 0.6-fold over control) nearly twice as high as that in sco5351 (13.8 ± 3.2-fold over control). Transcription of this gene increased to 72.4 ± 24.2-fold in M145 but was reduced to 6.5 ± 1.6-fold in sco5351 at 60 h, a difference of greater than tenfold between the two strains. Expression remained high in M145 (72 h, 68.1 ± 1.5; 84 h, 102.1 ± 13.2) but decreased further to nearly basal levels in sco5351 (72 h, 2.4 ± 0.1; 84 h, 2.7 ± 0.1), resulting in even greater differences between M145 and sco5351. We also examined the transcription of actII-1 (sco5082), which encodes the transcriptional regulator actR that controls the transporter genes actII-orf2 and actII-orf3 (Ahn et al. 2007) , and which is divergently transcribed from actII-orf2 (sco5083). Our analysis indicated that the temporal expression pattern of actII-1 (sco5082) was similar to that of actII-orf4 (sco5085) in the two strains.
Overall, our data indicated that the genes of the ACT pathway, including structural genes, an exporter gene, and regulatory genes, have markedly lower expression in sco5351 at time points that correlate with active ACT biosynthesis, consistent with the reduced production of ACT by sco5351.
SCO5351 activates the CDA pathway including cdaR in the early growth phase
Our bioassay analysis revealed that production of CDA is reduced in sco5351 (Fig. 2E) , suggesting that SCO5351 has a positive impact on CDA production. We hypothesized that, similar to the ACT cluster genes, genes of the CDA cluster may also be downregulated in sco5351. Therefore, transcription of the CDA cluster genes was compared between M145 and sco5351, using the same RNA extracts used for analysing the ACT cluster. The CDA cluster is composed of 40 genes (sco3210-3249) dedicated to the construction of the CDA complex (Fig. 4A) . To obtain a general understanding of the transcription patterns of the entire CDA pathway in the two strains, we selected a representative gene from each operon, with the expression of that gene in M145 at 24 h arbitrarily set to one. The CDA cluster contains a pathway-specific regulatory gene cdaR (sco3217), whose temporal expression pattern was investigated first (Fig. 4B) . The expression of cdaR was already lower at 24 h in sco5351 (0.29 ± 0.05) compared with M145 (1.0), suggesting that SCO5351 affects cdaR during the early growth phase. Transcription of cdaR peaked in both strains at 36 h, reaching 86.1 ± 3.4-fold in M145 and 39.2 ± 3.6-fold in sco5351, a value less than half that of the wild-type strain. The expression level of cdaR then decreased, becoming comparable in the two strains, except at 60 h when expression was lower in M145 than in sco5351. In addition, transcription of the CDA cluster-linked TCS absA1/absA2, which affects multiple antibiotics in S. coelicolor (Anderson, Brian and Champness 2001; Ryding, Anderson and Champness 2002) , was examined. As with cdaR, transcription of absA1 and absA2 was most markedly reduced at 36 h in sco5351 compared with M145, although the expression patterns at later time points differed from that of cdaR.
We then investigated the expression of structural genes in the CDA pathway: sco3215, which encodes a hypothetical protein and is the first gene of the sco3215-3210 operon, was already expressed at lower levels in sco5351 at 24 h (0.35 ± 0.11), but then expression dramatically increased to peak levels in both strains by 36 h, reaching 933 ± 156-fold for M145 and 427 ± 145-fold for sco5351. Expression levels of sco3215 decreased thereafter, maintaining comparable levels in both strains at 48 h and 60 h but higher levels in M145 at 72 h and 84 h. For sco3218, which encodes a small conserved protein, a notably lower expression level was detected at 24 h in sco5351. However, as for other CDA cluster genes, the most striking difference was detected at 36 h, with a 591.2 ± 4.1-fold change in M145 but only 160.6 ± 64.1-fold in sco5351. Expression of sco3218 was reduced in M145 thereafter and remained roughly comparable between these two strains, except at 60 h, when expression was higher in sco5351. Expression of sco3229, encoding a 4-hydroxyphenylpyruvic acid deoxygenase, peaked at 36 h for both strains but with a notably lower value in sco5351 (163.1 ± 61.2-fold) than in M145 (256.5 ± 40.8-fold). The largest difference in sco3229 expression was detected at 48 h (227.2 ± 16.3-fold in M145 vs. 45.1 ± 8.1-fold in sco5351), whereas levels were similar between these two stains at later time points; cdaPSI (sco3230), one of three peptide synthetase genes in the CDA cluster, was markedly downregulated in the mutant strain at 36 h (58.6 ± 8.1-fold in M145 vs. 37.3 ± 1.1-fold in sco5351) and 48 h (32.3 ± 3.3-fold in M145 vs. 21.6 ± 3.3-fold in sco5351), but not at the later time points. Transcription of cdaPSII (sco3231) was also notably reduced in sco5351 at 36 h and 48 h, but not at later time points. As with all of the CDA genes tested, fabH4 (sco3246), which encodes an aoxoacyl-[acyl carrier protein] synthase III and is located at the other end of the CDA cluster, exhibited markedly reduced expression at 36 h in sco5351 (1487 ± 318-fold) compared with M145 (2235 ± 419-fold), with both strains showing decreased transcription after this time point.
Altogether, our transcriptional analysis indicated that CDA pathway genes are expressed at lower levels in sco5351 but that this reduced expression is limited to the early time points, consistent with the weak CDA activity at the early growth phase of sco5351.
Deletion of SCO5351 delays formation of aerial mycelium and spores
Although the overall growth of S. coelicolor was not obviously affected by deletion of sco5351 (Fig. 2B ), sco5351 displays a moderate delay in morphological development when compared with M145 (Fig. 5A ). This delay was most obvious at 84 h and 96 h, diminished at 108 h, and was no longer evident at 120 h under the conditions tested ( Fig. 5A and data not shown). To confirm the defect in morphological development in sco5351, SEM was performed using samples grown for 96 h on YBP medium (Fig. 5B) . SEM images demonstrated that, while most of the aerial mycelium had clearly matured into spore chains in M145 and the complemented strain C-sco5351, only a small amount of aerial mycelium had matured into spore chains in sco5351 (Fig. 5B) , confirming the delayed development of sco5351.
Differential expression of chp and rdl genes in sco5351
The outer layer of aerial mycelium is coated with a hydrophobic sheath, composed of chaplin and rodlin proteins, which is absent in the vegetative mycelium (Elliot et al. 2003) . To investigate the potential impact of SCO5351 on chp and rdl genes, real-time PCR was performed using RNA extracted at 12-h intervals from 60 h to 84 h, the period of obvious developmental delay in sco5351. Expression of each gene at 60 h in M145 was arbitrarily set to one (Fig. 5C ). Transcription of chpB (sco7257) was notably reduced in sco5351 at 72 h (5.3 ± 0.66-fold in M145 vs. 2.4 ± 0.11-fold in sco5351) and 84 h (11.1 ± 2.1-fold in M145 vs. 4.2 ± 0.11-fold in sco5351). Markedly reduced expression was detected in sco5351 for chpC (84 h), chpD (72 h and 84 h), chpG (84 h), rdlA (72 h and 84 h) and rdlB (72 h), consistent with the delayed formation of aerial mycelium and spores in sco5351.
Protein dimerization may be required for the biological function of SCO5351
SCO5351 does not contain a typical DNA-binding motif, and although it could be expressed in soluble form, we were unable to detect SCO5351 binding to the promoters of actII-orf4 or cdaR, or to other DNA templates. BLAST analysis revealed three amino acids (K 106 , P 107 and F 108 ) potentially involved in forming a dimerization interface in SCO5351 (Fig. 6A) . To investigate the impact of these three residues on SCO5351 function, the DNA sequence encoding KPF was mutated to encode triplet alanine residues (AAA) in pCom-5351, generating pCom-5351-DM. Following sequence confirmation of the mutation, pCom-5351-DM was introduced into sco5351 to obtain strain C-sco5351-DM. Compared with C-sco5351, which produced ACT at levels comparable to those of M145, ACT production in C-sco5351-DM was minimal, similar to that of sco5351 (Fig. 6B) . To investigate whether SCO5351 dimerizes in vitro, purified His-tagged SCO5351 was electrophoresed under nondenaturing conditions, revealing two major protein bands, one corresponding to monomeric SCO5351 and the other to dimeric SCO5351 (Fig. 6D) . However, the only major band detected for SCO5351-DM corresponded to the monomer (Fig. 6D ). These findings suggest that KPF are critical for the activity of SCO5351 and for dimer formation, and therefore that the dimer form may be required to activate ACT production.
DISCUSSION
Our findings suggest that SCO5351 is a pleiotropic regulator involved in secondary metabolism and development, as reflected by the strikingly reduced production of ACT and delayed spore formation following deletion of SCO5351. Our extensive transcriptional analysis indicated that genes of the ACT pathway are all markedly reduced in sco5351 at the mid to late time points, consistent with the lower ACT synthesis during these time periods. Production of this pigmented antibiotic usually coincides with the transition from vegetative to reproductive growth (van Wezel and McDowall 2011) , and under our test conditions, ACT synthesis was evident by 72 h. In contrast, CDA was detectable as early as 36 h in M145 and the complemented strain, whereas only minimal activity was observed in sco5351 at this time. Our transcriptional analysis demonstrated that genes of the CDA pathway are decreased only at the early time points (24 h and 36 h) in the mutant, consistent with the delayed production of CDA. We also showed that expression of the two pathway-specific regulatory genes, actII-orf4 for ACT and cdaR for CDA, is downregulated in the mutant strain, suggesting that SCO5351 functions as an antibiotic regulator by controlling pathway-specific regulatory genes, whether by a direct or indirect effect. ACT is the signature metabolite produced by S. coelicolor. The ACT gene cluster is composed of more than 20 genes, including the regulatory gene actII-orf4 (sco5085). ACT production is a complex process that can be influenced by many environmental or genetic factors (van Wezel and McDowall 2011; Liu et al. 2013) , including many regulatory proteins, some of which exert their control over actII-orf4 (Liu et al. 2013) . Binding sequences for multiple regulators were revealed in the intergenic region upstream of actII-orf4, including sites for AfsQ1 (Wang et al. 2013) , AtrA (Ohnishi et al. 2005) , DasR (Rigali et al. 2008) , DraR (Yu et al. 2012) and GlnR (He et al. 2016) , indicating complex regulation of actII-orf4 and ACT production. Bioinformatics analysis indicated that SCO5351 has a CheY-like receiver domain (from amino acid residues 9 to 122) at the N-terminus, suggesting that SCO5351 is a response regulator. However, SCO5351 does not contain an identifiable DNA-binding domain and therefore might be unable to interact directly with the sequence upstream of actII-orf4 or with any other sequence. It is possible that SCO5351 impacts the ACT pathway by interacting with other factor(s) that can directly regulate actII-orf4. Bacterial response regulators lacking a DNA-binding domain are not uncommon, and instead of a DNAbinding domain, these response regulators have an enzymatic, RNA-binding, protein-or ligand-binding domain, or domains of unknown function (Galperin 2006; Galperin 2010) . No sequence similar to any domain/module was identified in the C-terminus of SCO5351, i.e. from residues 123 to 166, implying that SCO5351 is either a response regulator with a stand-alone receiver domain or a response regulator of the OsaB-type with an uncharacterized domain (Galperin 2006) . Some regulatory proteins function in dimeric or multimeric forms (Tschowri et al. 2014) , and protein dimerization is required before they can exert their roles. Protein dimerization can be mediated by c-di-GMP in Streptomyces (Tschowri et al. 2014 ) but mostly occurs through a dimerization interface composed of a few conserved amino acids (Lin et al. 2014) . Our findings suggest that dimerization of SCO5351 is critical for its function, possibly through formation of homo-dimers or multimers. However, we could not exclude the possibility that SCO5351 also forms a hetero-dimer or multimers with other proteins and that this hetero form has biological functions. Further study is needed to identify potential interacting proteins and to fully understand the regulatory mechanisms of SCO5351. Overall, knowledge on SCO5351 is very limited. It has been reported that transcription of sco5351 is controlled by WblA, a pleiotropic downregulator of antibiotic biosynthesis (Kang et al. 2007 ) whose mutation leads to overproduction of ACT. Transcription of sco5351 was markedly lower in a wblA mutant (Kim et al. 2011) , consistent with a positive role for SCO5351 in ACT production. Transcriptomic analysis by another group indicated that sco5351 is among those genes upregulated in the late growth phase (Yague et al. 2013) , suggesting that sco5351 is developmentally regulated, which is in agreement with our observation that SCO5351 impacts the expression of chp and rdl genes involved in forming the outer sheath of the aerial mycelium.
As our bioinformatics analyses indicate that SCO5351 is highly conserved in Streptomyces, further investigations of this protein and its homologues should provide insights into the regulation of secondary metabolites and development in this genus.
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